Fungal Infection Lungs
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Fungal Infection Lungs trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Fungal Infection Lungs trials you may qualify forThe protocol will be carried out in accordance with International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Go…
Evaluate new diagnostic methods using qPCR on non-invasive samples, compared with reference techniques for the positive diagnosis of pneumocystis (PcP) in immun…
An open-label study will evaluate effects of Benralizumab in the treatment of severe asthma in patients with allergic bronchopulmonary aspergillosis
To evaluate the efficacy and safety of biological agents in patients with allergic bronchopulmonary aspergillosis.
While ABPA and CPA represent two distinct manifestations of Aspergillus-related lung disease, there is an overlap of investigations that are currently used for…
The goal of this study is to learn how the body's immune system affects disease control in people with different airway inflammatory diseases.We want to underst…
This study will examine the effectiveness of a new laboratory method for detecting pneumocystis organisms in a salt-water (saline) oral wash. Pneumocystis infec…
To assess the safety and efficacy of nebulized PC945 in combination with systemic antifungal therapy for the treatment of refractory IPA
A study to evaluate the safety and tolerability of opelconazole for the prevention of fungal aspergillus infections in the lung in participants who have receive…